ACET
Adicet Bio Inc
5.70$
-7.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.9% | +51.4% | -39.6% | +61.3% | -332.4% | – | -48.5% | +71.5% | -361.9% | – | +19.3% | -313.3% | – | +1.6% | +273.3% | -59.4% | +78.7% | -173.6% | – | -28.8% | +59.5% | +357.0% | -100.0% | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -2.5% | +56.0% | -48.6% | -100.0% | +10,618,566.7% | -50.3% | -64.2% | +145.0% | +129.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | +6.7% | +9.7% | +52.6% | +1.9% | +25.8% | +2.8% | -28.1% | -2.2% | -3.0% | -0.6% | – | – | -4.8% | +0.0% | -7.9% | -8.9% | – | – | |
| – | -0.1% | +37.4% | -8.3% | -100.0% | – | – | +41.3% | -34.9% | -3,039.8% | – | +19.3% | -313.3% | – | – | +273.3% | -59.4% | +78.7% | -173.6% | – | -28.8% | +59.5% | +357.0% | -104.3% | – | – | – | – | – | – | -114.7% | – | – | – | -151.6% | – | – | – | – | – | – | |
| – | +27.7% | +94.4% | +12.7% | +13.4% | +198.6% | -18.5% | +46.1% | -42.9% | +257.4% | -79.3% | +16.3% | +8.6% | +3.0% | +7.8% | +23.4% | +3.1% | +8.3% | +26.0% | -13.0% | +12.3% | +22.9% | -8.0% | +20.0% | +2.4% | +51.0% | +7.0% | +6.0% | -7.7% | -5.4% | -3.5% | +8.4% | +1.4% | -11.4% | -2.0% | +24.6% | -19.6% | +9.6% | -30.2% | +5.5% | – | |
| – | +33.5% | -5.5% | -95.5% | +2,482.8% | +72.6% | -96.1% | +8.3% | 0.0% | +1,980.1% | -95.5% | -1.7% | -11.8% | +42.0% | -3.8% | +193.9% | +4.3% | -34.4% | +10.9% | -10.7% | +3.7% | +21.8% | +7.1% | -4.0% | -1.7% | +2.1% | +0.2% | -0.6% | +1.6% | +2.6% | +2.5% | -0.4% | -0.7% | +8.3% | -5.3% | -43.9% | +28.5% | +34.3% | -40.4% | -5.7% | – | |
| – | +33.2% | -1.0% | -85.8% | -4.9% | -1,211.1% | – | +38.4% | -36.0% | -354.4% | – | -13.5% | +34.2% | +11.8% | +4.5% | +68.4% | +3.7% | -11.5% | +17.7% | -10.0% | +9.6% | +22.6% | -3.5% | +11.9% | +1.2% | +37.3% | +5.6% | +4.7% | +49.8% | -39.6% | -7.4% | +12.4% | +0.9% | -7.3% | -2.8% | +8.4% | -13.7% | +14.1% | -36.6% | +10.2% | – | |
| – | -84.1% | +847.1% | +162.8% | -111.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -582.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +19.5% | +99.4% | -39.4% | +66.0% | -11.0% | +5.8% | -93.5% | +1,777.1% | -22.4% | – | – | – | – | -84.6% | -89.4% | +47.1% | +0.0% | +0.0% | +2.0% | -2.0% | -50.0% | -28.0% | +0.0% | +0.0% | +44.4% | -26.9% | -78.9% | -75.0% | +4,800.0% | -95.9% | -100.0% | – | +0.0% | -100.0% | – | – | +100.0% | -4.2% | -4.3% | – | |
| – | -113.8% | – | +364.0% | -108.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -588.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -115.4% | – | +383.5% | -88.1% | -1,091.3% | – | -100.6% | – | – | – | -88.9% | +1,100.0% | +50.0% | -14,983.3% | – | +200.0% | -4,733.3% | – | +60.4% | -85.7% | 0.0% | +700.1% | -292.0% | – | – | – | – | – | – | +6.1% | -199.6% | – | – | – | – | – | – | – | – | – | |
| – | -112.9% | – | +353.8% | -113.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -588.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -49.0% | +245.7% | +35.5% | -110.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -543.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.